NCT02647099 2026-03-13
ALASCCA
Karolinska Institutet
Phase 3 Active not recruiting
Clinical Trials
21 trialsNCT02394769 2025-12-04
ASPIRED
Massachusetts General Hospital
Phase NA Active not recruiting
NCT02467582 2025-05-16
Adjuvant Aspirin Treatment for Colon Cancer Patients
Swiss Cancer Institute
Phase 3 Terminated
NCT00357682 2025-05-01
AspECT
University of Oxford
Phase 3 Completed
NCT02834403 2023-12-15
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
The Methodist Hospital Research Institute
Phase 1/2 Completed
NCT00578721 2023-07-07
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
Phase 2 Completed
NCT02927249 2023-04-05
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT03103152 2023-03-29
PROVENT
Queen Mary University of London
Phase 2/3 Completed
NCT03396952 2022-10-13
Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma
University of California, San Francisco
Phase 2 Completed
NCT04352439 2022-09-26
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Phase 4 Completed
NCT03093207 2020-11-17
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
Universidade Estadual Paulista Júlio de Mesquita Filho
Phase 2/3 Completed
NCT01763606 2020-08-14
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01696760 2018-12-05
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT00790842 2018-10-24
PrE1003
PrECOG, LLC.
Phase 1/2 Terminated
NCT01355705 2018-09-18
Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma
Stanford University
Phase 1/2 Completed
NCT01965002 2018-05-23
Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
Stanford University
Phase NA Terminated
NCT00263211 2017-03-15
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Washington University School of Medicine
Phase 2 Terminated
NCT00691704 2014-08-19
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Duke University
Phase 2 Completed
NCT00501345 2012-08-01
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00000479 2012-06-15
WHS
Brigham and Women's Hospital
Phase 3 Completed
NCT00790452 2011-12-08
Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma
M.D. Anderson Cancer Center
Phase 2 Terminated